Chinese pharmaceutical company Northeast Pharmaceutical Group plans to acquire 60% stake in a medicine company based in Dandong, China, through its subsidiary for CNY3.9m ($0.57m).
Venture capital firm Principia, along with the Principia Health Fund, has announced the acquisition of 70% stake in pharmaceutical company Trifarma.
All entities involved in the acquisition are based in Italy. The acquisition will enable Principia to launch new products in the Italian market.
Creador III’s affiliate Commelina has announced the acquisition of 22% stake in Indian healthcare and medical services provider Paras Healthcare for Rs2.75bn ($42.7m).
Creador is a private equity firm based in Malaysia.
See Also:
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData